To evaluate the impact of TNBC molecular heterogeneity on the abscopal response, we selected four p53-null BALB/c mammary tumor allograft models spanning basal (2336R, 2225L) and luminal-like (2250L, 2208L) subtypes42,43. This evidence concerns the gene TP53 and breast cancer.